草药及其活性成分用于胃癌和相关问题 - 临床前和临床研究
Pragya Singh1, Neelam Singh2, Dheeraj Nagpal1
1Amity Institute of Pharmacy, Amity University Uttar Pradesh, Sector 125, Noida201313, India.
Current protein & peptide science
|May 7, 2025
概括
草药产品显示出作为补充胃癌治疗的承诺,可能增强传统疗法并减少副作用. 需要进一步的临床试验来确认它们在人类中的有效性和安全性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 胃癌是全球癌症死亡的主要原因之一.
- 传统的治疗方法 (化疗,辐射,手术) 有局限性,包括副作用和低效率.
- 先进的诊断阶段和复杂的治疗方案在胃癌管理中提出了重大挑战.
研究的目的:
- 审查草药产品及其生物活性化合物的潜力,作为胃癌的替代或辅助疗法.
- 评估临床前和临床证据,支持植物成分的抗胃癌特性.
- 突出需要严格的临床试验来验证基于草药的胃癌治疗的疗效和安全性.
主要方法:
- 对胃癌的草药化合物的体内实验和临床试验的审查.
- 对植物成分的有效性和安全性现有文献的分析.
- 发现研究缺陷,特别是缺乏大规模的III期临床试验.
主要成果:
- 在体内研究表明,草药化合物可以增强传统的抗癌治疗,并减轻其毒性.
- 临床试验表明,植物成分对人类有潜在的抗胃癌作用.
- 临床前的承诺并没有显著地转化为临床实践,原因是缺乏高质量的人体试验.
结论:
- 草药产品为胃癌的预防和治疗提供了一个有希望的途径,可能补充传统方法.
- 精心控制的人体干预研究对于确定草药疗法的疗效和安全性至关重要.
- 未来的研究可能会导致将草药产品整合到功能性食品和用于胃癌管理的药品中,从而最大限度地减少副作用.
相关概念视频
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Gastritis III: Clinical Manifestations and Management
91
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
91
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Peptic Ulcer Disease IV: Management
45
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
45
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
365
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
365
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
298
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
298


